DK0843732T3 - Sekvens af naturlige eller syntetiske retroelementer, der muliggör indsætning af nukleotidsekvenser i en eukaryot celle - Google Patents

Sekvens af naturlige eller syntetiske retroelementer, der muliggör indsætning af nukleotidsekvenser i en eukaryot celle

Info

Publication number
DK0843732T3
DK0843732T3 DK96927085T DK96927085T DK0843732T3 DK 0843732 T3 DK0843732 T3 DK 0843732T3 DK 96927085 T DK96927085 T DK 96927085T DK 96927085 T DK96927085 T DK 96927085T DK 0843732 T3 DK0843732 T3 DK 0843732T3
Authority
DK
Denmark
Prior art keywords
sequence
natural
nucleotide sequences
eukaryotic cell
allowing insertion
Prior art date
Application number
DK96927085T
Other languages
English (en)
Inventor
Andre Choulika
Jean-Francois Nicolas
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Application granted granted Critical
Publication of DK0843732T3 publication Critical patent/DK0843732T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK96927085T 1995-08-07 1996-07-25 Sekvens af naturlige eller syntetiske retroelementer, der muliggör indsætning af nukleotidsekvenser i en eukaryot celle DK0843732T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9509587A FR2737731B1 (fr) 1995-08-07 1995-08-07 Sequence de retroelements naturels ou synthetiques ayant pour fonction de permettre l'insertion de sequences nucleotidiques dans une cellule eucaryote

Publications (1)

Publication Number Publication Date
DK0843732T3 true DK0843732T3 (da) 2007-01-22

Family

ID=9481767

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96927085T DK0843732T3 (da) 1995-08-07 1996-07-25 Sekvens af naturlige eller syntetiske retroelementer, der muliggör indsætning af nukleotidsekvenser i en eukaryot celle

Country Status (11)

Country Link
US (2) US6200800B1 (da)
EP (2) EP1760154B1 (da)
JP (2) JP4173543B2 (da)
AT (2) ATE477326T1 (da)
CA (1) CA2226301C (da)
DE (2) DE69636546T2 (da)
DK (1) DK0843732T3 (da)
ES (1) ES2276407T3 (da)
FR (1) FR2737731B1 (da)
PT (1) PT843732E (da)
WO (1) WO1997006271A1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2737731B1 (fr) * 1995-08-07 1997-10-10 Pasteur Institut Sequence de retroelements naturels ou synthetiques ayant pour fonction de permettre l'insertion de sequences nucleotidiques dans une cellule eucaryote
US5928914A (en) * 1996-06-14 1999-07-27 Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University Methods and compositions for transforming cells
US6534314B1 (en) 1996-06-14 2003-03-18 Massachusetts Institute Of Technology Methods and compositions for transforming cells
US6410317B1 (en) * 1999-07-14 2002-06-25 Clontech Laboratories, Inc. Recombinase-based methods for producing expression vectors and compositions for use in practicing the same
GB2355459B (en) 1999-11-29 2001-09-26 Isis Innovation A dominant conditional lethal genetic system
ATE427994T1 (de) 2000-04-12 2009-04-15 Dana Farber Cancer Inst Inc Selbstlíschende rekombinasen, dafur kodierende nukleinsauren und verfahren zu deren verwendung
US20040231006A1 (en) * 2000-04-12 2004-11-18 Silver Daniel P. Self-extinguishing recombinases, nucleic acids encoding them and methods of using the same
US7101541B2 (en) 2000-05-19 2006-09-05 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Utilization of non-viral sequences for minus-strand DNA transfer and gene reconstitution
GB2402675B (en) * 2003-05-12 2008-02-20 Oxitec Ltd Resistance dilution
GB2403475B (en) 2003-07-01 2008-02-06 Oxitec Ltd Stable integrands
GB2404382B (en) 2003-07-28 2008-01-30 Oxitec Ltd Pest control
JP4927730B2 (ja) * 2005-07-05 2012-05-09 一般財団法人化学及血清療法研究所 改変トランスポゾンベクター及びその利用方法
GB2443186A (en) 2006-10-25 2008-04-30 Oxitec Ltd Expression system for mediating alternative splicing
GB2500113A (en) 2012-03-05 2013-09-11 Oxitec Ltd Arthropod male germline gene expression system
GB201303932D0 (en) 2013-03-05 2013-04-17 Oxitec Ltd Muscle actin promoter
GB2526867A (en) 2014-06-05 2015-12-09 Oxitec Ltd Gene expression system
BR112019002771A2 (pt) 2016-08-12 2019-05-14 Oxitec Ltd polinucleotídeo de módulo de controle de união de doublesex, sistema de expressão de gene, plasmídeo vetor de expressão, inseto geneticamente engenheirado, métodos para produzir insetos geneticamente engenheirados, para cultivar seletivamente insetos macho geneticamente engenheirados, para reduzir uma população de inseto selvagem, para criar um mosquito aedes aegypti transgênico e para detectar a presença de uma molécula de dna, local alvo cromossômico de aedes aegypti, mosquito aedes aegypti geneticamente engenheirado, molécula de dna, e, kit de detecção de dna.
AR117409A1 (es) 2018-03-29 2021-08-04 Oxitec Ltd Noctuidas autolimitantes

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61502885A (ja) 1984-08-06 1986-12-11 ヒル．ロバ−ト ロツク式チユ−ブ巻取り装置
US5219740A (en) * 1987-02-13 1993-06-15 Fred Hutchinson Cancer Research Center Retroviral gene transfer into diploid fibroblasts for gene therapy
NZ225470A (en) * 1987-07-21 1990-06-26 Du Pont Stable and viable recombinant viral vectors
FR2629469B1 (fr) * 1988-03-31 1990-12-21 Pasteur Institut Retrovirus recombinant defectif, son application a l'integration de sequences codantes pour des proteines determinees dans le genome de cultures cellulaires infectables par le retrovirus sauvage correspondant et adns recombinants pour la production de ce retrovirus recombinant
US5658775A (en) * 1988-05-17 1997-08-19 Sloan-Kettering Institute For Cancer Research Double copy retroviral vector
DE69123981T3 (de) * 1990-10-31 2006-06-14 Cell Genesys Inc Nützliche retrovirale vektoren für die gentherapie
US5629159A (en) * 1995-06-07 1997-05-13 California Institute Of Technology Immortalization and disimmortalization of cells
FR2737731B1 (fr) * 1995-08-07 1997-10-10 Pasteur Institut Sequence de retroelements naturels ou synthetiques ayant pour fonction de permettre l'insertion de sequences nucleotidiques dans une cellule eucaryote

Also Published As

Publication number Publication date
JPH11510391A (ja) 1999-09-14
CA2226301A1 (fr) 1997-02-20
JP4482578B2 (ja) 2010-06-16
EP0843732B1 (fr) 2006-09-13
WO1997006271A1 (fr) 1997-02-20
US20060269522A1 (en) 2006-11-30
US6200800B1 (en) 2001-03-13
DE69638235D1 (de) 2010-09-23
JP4173543B2 (ja) 2008-10-29
ES2276407T3 (es) 2007-06-16
FR2737731B1 (fr) 1997-10-10
EP0843732A1 (fr) 1998-05-27
JP2008086321A (ja) 2008-04-17
EP1760154A2 (fr) 2007-03-07
PT843732E (pt) 2007-01-31
EP1760154B1 (fr) 2010-08-11
DE69636546T2 (de) 2007-08-02
ATE477326T1 (de) 2010-08-15
CA2226301C (fr) 2011-04-19
HK1105662A1 (zh) 2008-02-22
ATE339511T1 (de) 2006-10-15
DE69636546D1 (de) 2006-10-26
FR2737731A1 (fr) 1997-02-14
EP1760154A3 (fr) 2007-03-14

Similar Documents

Publication Publication Date Title
DE69638235D1 (de) Sequenzen von natürlischen oder synthetischen Retroelementen, die die Insertion von nukleotiden Sequenzen in eukaryotische Zellen erlauben
ATE321883T1 (de) DE NOVO ODER ßUNIVERSALERß SEQUENZIERUNGS-ARRAY
DK1071804T3 (da) Anvendelse af triplex-struktur-dna-sekvenser til overførsel af nukleotidsekvenser
ATE428809T1 (de) Nukleinsäure-primer und -sonden zur detektion von hiv-1 und hiv-2
DK0887427T3 (da) Amplifikation og detektion af HIV-1 og/eller HIV-2
DK605987A (da) Bestemte dna-sekvenser afledt af et papillomavirus-genom, deres anvendelse til in vitro diagnoseformaal og fremstilling af antigeniske praeparater bestemte dna-sekvenser afledt af et papillomavirus-genom, deres anvendelse til in vitro diagnoseformaal og fremstilling af antigeniske praeparater
ATE214095T1 (de) Verwendung einer exo-nukleotidprobe in der genklonierung
ATE520783T1 (de) Lentivirale vektoren
ATE364718T1 (de) Verfahren zur vervielfältigung von nukleinsäure
EP1895010A3 (en) Vectors based on equine infectious anemia virus (vaie)
DK0403333T3 (da) Nukleotidsekvenser stammende fra genomet i retrovirus af typen HIV-1, HIV-2 og SIV og deres anvendelse, fortrinsvis til opf
DK634386A (da) Vektorer til ekspression og sekretion af hirudin fra transformeret gaer
ATE374253T1 (de) Nukleotiden-sequenzen aus retroviren-antigenen hiv-i gruppe (oder untergruppe) o
FI904494A0 (fi) Diagnos- och amplifieringsfoerfaranden foer eliminering av ett primer-maol-opar i primerns 3'-aenda.
NO980212L (no) Primere pÕvisning av HIV-1
ATE124993T1 (de) Pflanzen, resistent gegen den anti-sens rns aufweisenden virus.
RU98100921A (ru) Праймеры для обнаружения вич-1
DE3778096D1 (de) Mittels nitriddispersion verstaerkter stahl.
ES8900170A1 (es) Procedimiento de modificacion de celulas eucariotas.
DE69825269D1 (de) Nachweis von retroviralen untertypen auf der basis der spezifischen sequenzen der hülle
MX9305183A (es) Intron portatil, molecula de adn genomico viral, virus vivo y vacuna que los contiene y metodo para su obtencion.
DK0880594T3 (da) Retroviral vektor og dens anvendelse i genterapi
Ballaun Charakterisierung der spezifischen Interaktion transregulatorischer Proteine humaner Retroviren (HIV-1, HTL-VI) mit ihren RNA-Zielsequenzen.
EP1193313A4 (en) METHOD FOR DETERMINING AN HIV-1 SUB-TYPE
Dunwiddie IDENTIFICATION AND CHARACTERIZATION OF ENDOGENOUS VIRUS-LIKE SEQUENCES IN THE EV CHICKEN AND JAPANESE QUAIL (REVERSE TRANSCRIPTASE, CELLULAR HOMOLOG)